BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Drug Development

  New England Journal of Medicine Publishes Two Positive Phase 3 Trials Showing DUPIXENT® (dupilumab) Improved Moderate-to-Severe Asthma

  Results showed DUPIXENT demonstrated a significant improvement in multiple asthma endpoints in two Phase 3 clinical trials.

  May 21, 2018

   · 

  23 min read
• Scioto Biosciences Closes $1.8M in Series A Financing, Receives NIH and State of Indiana Grants Funding to Support Launch of New Microbiome Platform Technology

  The funding represents a first-time interstate collaboration between two Indiana-based investors.

  May 21, 2018

   · 

  5 min read
• Cerapedics Announces Presentation of Results from the IVANOS Study of i-FACTOR™ Peptide Enhanced Bone Graft in Uninstrumented Lumbar Posterolateral Spine Surger

  Cerapedics, a privately-held orthobiologics company, today announced results from the IVANOS study evaluating i-FACTOR™ Peptide Enhanced Bone Graft in lumbar posterolateral spine surgery.

  May 21, 2018

   · 

  4 min read
• Business

  Indiana Biosciences Research Institute names executive director of engagement, communications and external affairs

  The Indiana Biosciences Research Institute (IBRI) today announced the appointment of Mark E. Craft as executive director of engagement, communications and external affairs.

  May 21, 2018

   · 

  2 min read
• Policy

  Navitus Health Solution’s Statement on Trump Administration’s Prescription Drug Cost-Reduction Plan

  In response to the Trump administration’s plan to reduce prescription drug costs, Navitus Health Solutions issued this response

  May 21, 2018

   · 

  3 min read
• Pharm Country

  Biotech Market Value Set to Grow Due to Technological Advancements

  FinancialBuzz.com News Commentary

  May 21, 2018

   · 

  11 min read
• Business

  Olympus Adds HANAROSTENT to EndoTherapy Portfolio through Exclusive Distribution Agreement

  Partnership with M.I. Tech Brings Strategic Roll-Out of Globally Recognized Medical Products to the U.S. Market

  May 21, 2018

   · 

  4 min read
• Pharm Country

  Henry Schein Rises To #238 On The FORTUNE 500®

  Company Celebrates 15 Years as One of America’s Largest Corporations

  May 21, 2018

   · 

  2 min read
• FDA

  FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure

  FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure.

  May 21, 2018

   · 

  3 min read
• FDA

  Glenmark Pharmaceuticals Announces the Company’s First New Drug Application for Ryaltris™ for Patients with Seasonal Allergic Rhinitis

  Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food & Drug

  May 21, 2018

   · 

  3 min read